J. Rebuck

K. Olsen, S. Kaufman, D. Collier, 2001, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

A Needs Assessment for Regionalization of Trauma Care in a Rural State

T. Osler, S. Shackford, F. Rogers, 2005, The American surgeon.

Daily evaluation of macroaspiration in the critically ill post-trauma patient.

F. Rogers, J. Ahern, J. Rebuck, 2005, Current surgery.

Potential Influence of Antisecretory Therapy on the Development of Candida-Associated Intraabdominal Infection

W. Charash, J. Rebuck, J. Hebert, 2008, The Annals of pharmacotherapy.

Evaluation of Feeding Intolerance in Patients with Pentobarbital-Induced Coma

Karen M Frock, B. Crookes, Janine Then, 2008, The Annals of pharmacotherapy.

Clinical aspiration-related practice patterns in the intensive care unit: A physician survey

K. Olsen, J. Rebuck, Jon R. Rasmussen, 2001, Critical care medicine.

Optimizing the Dose of Three‐Factor Prothrombin Complex Concentrate in Traumatic Brain Injury Patients on Warfarin Therapy

J. Rebuck, J. Costello, Thao K Huynh, 2014, Pharmacotherapy.

Caution and Patient Safety Concerns Should Guide Us

L. Welage, Ryan J Daley, J. Rebuck, 2005 .

Pharmacokinetics of Intravenous and Oral Levofloxacin in Critically Ill Adults in a Medical Intensive Care Unit

E. Abraham, D. Fish, J. Rebuck, 2002, Pharmacotherapy.

Survival of propofol infusion syndrome in a head-injured patient

F. Rogers, J. Rebuck, S. Corbett, 2006, Critical care medicine.

Pharmacokinetics of Intravenous Trovafloxacin in Critically Ill Adults

D. Fish, K. Olsen, J. Rebuck, 2000, Pharmacotherapy.

Experience with Vancomycin in Patients Receiving Slow Low-Efficiency Dialysis

J. Ahern, C. Possidente, M. Weidner, 2004 .

Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy.

F. Rogers, P. Callas, J. Rebuck, 2007, The Journal of trauma.

Practical Considerations When Developing Guidelines for Managing Critical Bleeding

J. Rebuck, 2007, Pharmacotherapy.

Omeprazole‐Induced Exfoliative Dermatitis

M. Rybak, J. Rebuck, Cindy M. Weingarten, 1998, Pharmacotherapy.

Propylene Glycol–Induced Lactic Acidosis in a Patient with Normal Renal Function: A Proposed Mechanism and Monitoring Recommendations

M. Young, E. Mesler, W. J. Weise, 2005, The Annals of pharmacotherapy.

J. Rebuck, S. Corbett, Jill A. Rebuck, 2008, Journal of intensive care medicine.

Proton-pump inhibitors for upper-gastrointestinal bleeding.

H. Cohen, J. Rebuck, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Case report: Morgagni hernia

F. Rogers, J. Rebuck, 2006, Hernia.

Infantile Gastroesophageal Reflux: Adherence to Treatment Guidelines in the Hospital Setting.

J. Rebuck, H. Long, Lauren V Solski, 2018, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Arthralgias and myalgias related to quinupristin-dalfopristin administration.

M. Rupp, M E Rupp, K. Olsen, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Thrombocytopenia-associated costs in an adult intensive care unit population

G. Cochran, G. Yee, K. Olsen, 1999 .

The Critical Care Pharmacist: An Essential Intensive Care Practitioner

J. Papadopoulos, S. Pass, J. Rebuck, 2002, Pharmacotherapy.

W. Coplin, D. Rhoney, J. Rebuck, 2000, Journal of neurology, neurosurgery, and psychiatry.

Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?

T. Osler, M. Healey, F. Rogers, 2004, Current surgery.

Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation*

M. Healey, B. Leavitt, P. Callas, 2005, Critical care medicine.

In vitro activities of parenteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic Escherichia coli host.

P. Fey, M. Rupp, K. Olsen, 2000, The Journal of antimicrobial chemotherapy.